stoxline Quote Chart Rank Option Currency Glossary
  
ThermoGenesis Holdings, Inc. (THMO)
0.0003  -0 (-0%)    02-11 15:00
Open: 0.0005
High: 0.0005
Volume: 59,691
  
Pre. Close: 0.000300000014
Low: 0.0001
Market Cap: 0(M)
Technical analysis
2025-02-11 4:49:54 PM
Short term     
Mid term     
Targets 6-month :  0 1-year :  0
Resists First :  0 Second :  0
Pivot price 0
Supports First :  0 Second :  0
MAs MA(5) :  0 MA(20) :  0
MA(100) :  0.03 MA(250) :  0.3
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  33.3 D(3) :  55.5
RSI RSI(14): 27.5
52-week High :  1.25 Low :  0
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ THMO ] has closed below the lower bollinger band by 0.0%. Bollinger Bands are 99.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 67 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0 - 0 0 - 0
Low: 0 - 0 0 - 0
Close: 0 - 0 0 - 0
Company Description

ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics in the United States, China, the United Arab Emirates, Vietnam, and internationally. The company provides medical device products for automated cell processing. Its clinical bio-banking applications include AXP II Automated Cell Separation System, an automated fully closed cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. The company's point-of-care applications include XP Point-of-Care System, an automated, fully closed, sterile system that allows for the rapid and automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; and PXP-1000 System, an automated, fully closed system that provides fast, reproducible separation of multiple cellular components from blood with minimal red blood cell contamination. Its cell processing products comprise X-Series products for general laboratory use, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The company also provides contract development and manufacturing services for cell and cell-based gene therapies. It markets and sells its medical device products through independent distributors, as well as direct to end-user customers. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California.

Headline News

Wed, 12 Jun 2024
Why Is ThermoGenesis (THMO) Stock Down 37% Today? - InvestorPlace

Wed, 12 Jun 2024
Why ThermoGenesis (THMO) Shares Are Down 40% - Benzinga

Sat, 15 Apr 2023
Top 4 Cord Blood Companies to Invest In (February 2025) - Securities.io

Wed, 12 Feb 2025

Wed, 12 Feb 2025

Wed, 12 Feb 2025

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
PNK
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 16 (M)
Shares Float 2 (M)
Held by Insiders 28 (%)
Held by Institutions 0 (%)
Shares Short 21 (K)
Shares Short P.Month 53 (K)
Stock Financials
EPS -3.99
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.11
Profit Margin -153.5 %
Operating Margin -20.4 %
Return on Assets (ttm) -25.5 %
Return on Equity (ttm) -802 %
Qtrly Rev. Growth 6.4 %
Gross Profit (p.s.) 0
Sales Per Share 0.6
EBITDA (p.s.) -0.31
Qtrly Earnings Growth 0 %
Operating Cash Flow -4 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow -0.01
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android